Analyze Diet

Topic:Drug

The topic of drugs and horses encompasses the study of various pharmacological agents used in equine medicine for therapeutic purposes. This includes the administration of medications for pain management, disease treatment, and performance enhancement. The pharmacokinetics and pharmacodynamics of drugs in horses are key areas of research, as they determine the absorption, distribution, metabolism, and excretion of these substances. Additionally, the topic covers the detection and regulation of substances in competitive equestrian sports to ensure fair play and animal welfare. This page compiles peer-reviewed research studies and scholarly articles that explore the effects, safety, and regulatory aspects of drug use in equine health and performance.
Continuous measurement of caffeine and two metabolites in blood and skeletal muscle of unrestrained adult horses by semi-automated in vivo microdialysis.
Journal of veterinary pharmacology and therapeutics    March 21, 2002   Volume 24, Issue 6 405-414 doi: 10.1046/j.1365-2885.2001.00364.x
Chou CC, Webb AI, Brown MP, Gronwall RR, Vickroy TW.Concentrations of caffeine (CA) and two metabolites were measured simultaneously in venous blood and splenius muscle of adult horses using a semi-automated in vivo microdialysis sampling technique. Dialysates from muscle and jugular vein were collected continuously for 48 h and drug levels were determined by high performance liquid chromatography (HPLC). Following i.v. injection, CA (3 mg/kg) attained a peak blood level of nearly 5400 +/- 600 ng/mL and decreased with a half-life of 15.3 +/- 0.7 h. Pharmacokinetic and statistical comparisons between CA concentrations in jugular dialysates and p...
Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats.
Journal of veterinary pharmacology and therapeutics    March 21, 2002   Volume 24, Issue 6 399-403 doi: 10.1046/j.1365-2885.2001.00362.x
Nebbia C, Ceppa L, Dacasto M, Nachtmann C, Carletti M.The oxidative metabolism of monensin, an ionophore antibiotic extensively used in veterinary practice as a coccidiostat and a growth promoter, was studied in hepatic microsomal preparations from horses, pigs, broiler chicks, cattle and rats. As assayed by the measurement of the amount of the released formaldehyde, the rate of monensin O-demethylation was nearly of the same order of magnitude in all species, but total monensin metabolism, which was estimated by measuring the rate of substrate disappearance by a high-performance liquid chromatography (HPLC) method, was highest in cattle, interme...
5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT(4) agonist.
Journal of veterinary pharmacology and therapeutics    March 5, 2002   Volume 25, Issue 1 49-58 doi: 10.1046/j.1365-2885.2002.00380.x
Weiss R, Abel D, Scholtysik G, Straub R, Mevissen M.The effects of 5-hydroxytryptamine (5-HT), HTF 919, a new 5-HT(4) agonist, and the antagonists SB 203-186 (5-HT(4)) and tropisetron (5-HT(3)) on intestinal motility were tested in vitro on isolated preparations of horse ileum and pelvic flexure. Concentration-response curves were created by cumulative application of the agonists with or without preincubation of the antagonists. The 5-HT preparation induced a concentration-dependent contraction in equine ileum and pelvic flexure. The results indicate that 5-HT receptors are present in all parts of equine intestine investigated in this study. Tr...
Detection of fenspiride and identification of in vivo metabolites in horse body fluids by capillary gas chromatography-mass spectrometry: administration, biotransformation and urinary excretion after a single oral dose.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    February 28, 2002   Volume 767, Issue 1 131-144 doi: 10.1016/s0378-4347(01)00556-4
Dumasia MC, Houghton E, Hyde W, Greulich D, Nelson T, Peterson J.Studies related to the in vivo biotransforrmation and urinary excretion of fenspiride hydrochloride in the horse are described. After oral administration, the drug is metabolised by both phase I functionalisation and phase II conjugation pathways. Following enzymatic deconjugation, fenspiride and its phase I metabolites were isolated from post-administration biofluids using bonded co-polymeric mixed mode solid-phase extraction cartridges to isolate the basic compounds. Following trimethylsilylation (TMS), the parent drug and metabolites were identified by capillary gas chromatography-mass spec...
Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    February 5, 2002   Volume 766, Issue 2 257-263 doi: 10.1016/s0378-4347(01)00506-0
Dehennin L, Bonnaire Y, Plou P.The dietary supplements 19-norandrostenedione and 19-norandrostenediol are potential metabolic precursors of nandrolone. They are considered by law in the United States as prohormones without proven therapeutic, curative or diagnostic properties, and therefore available as over-the-counter drugs. Oral dosages of 0.1-1 mg/kg body weight were readily absorbed in the equine intestinal tract and thereby led to urinary excretion of drastically increased 5alpha-estrane-3beta,17alpha-diol conjugates, which are known to be final metabolites of nandrolone. The actual rules for detection of illicit nand...
Plasma and synovial fluid concentrations of calcium pentosan polysulphate achieved in the horse following intramuscular injection.
Equine veterinary journal    February 2, 2002   Volume 34, Issue 1 61-64 doi: 10.2746/042516402776181123
Fuller CJ, Ghosh P, Barr AR.Results from in vitro studies have indicated that calcium pentosan polysulphate (CaPPS) may be of therapeutic value in osteoarthritis (OA) in the horse. However, no controlled clinical trials using this drug in equine OA have yet been reported. If CaPPS is to be developed for such use, the relationship between the proposed i.m. dose of CaPPS to be used and the concentrations of drug attained in plasma and synovial fluid of the target joint should first be established. An investigation was undertaken to determine these concentrations after a single 2 mg/kg i.m. injection of CaPPS. Blood and syn...
Effects of inhaled ipratropium bromide on breathing mechanics and gas exchange in exercising horses with chronic obstructive pulmonary disease.
Equine veterinary journal    January 31, 2002   Volume 34, Issue 1 36-43 doi: 10.2746/042516402776181132
Bayly WM, Duvivier DH, Votion D, Vandenput S, Art T, Lekeux P.Six Warmblood horses suffering an acute exacerbation of COPD were tested to investigate whether inhalation of ipratropium bromide (IB) dry powder (2,400 microg) 30 min preexercise would improve their exercise capacity. A cross-over protocol with an inert powder placebo (P) was used. Mechanics of breathing and arterial blood gases were determined before treatment, after treatment but pre-exercise, and during an incremental exercise test. Oxygen consumption (VO2) was also measured before and during exercise, and the time to fatigue recorded. Inhalation of IB reduced total pulmonary resistance (R...
Adverse drug reactions and interactions in the horse.
The Veterinary clinics of North America. Equine practice    January 10, 2002   Volume 17, Issue 3 445-vi doi: 10.1016/s0749-0739(17)30044-5
Brumbaugh GW.Drugs undergo extensive evaluation before they are marketed. The occurrence of adverse reactions, however, may be so rare that thousands of patients must receive the drug before reliable data are available. It is necessary that veterinarians be informed about the drugs they use, be able to recognize drug-associated complications, know how to evaluate the patient for evidence of drug-associated toxicity, report adverse effects of drugs to the respective manufacturers, and be prepared to provide medical support and antidotal treatment (if it exists) for a patient if toxicosis occurs.
Residues and considerations for use of pharmaceutics in the performance horse.
The Veterinary clinics of North America. Equine practice    January 10, 2002   Volume 17, Issue 3 433-444 doi: 10.1016/s0749-0739(17)30043-3
Kollias-Baker C.Analytic chemistry laboratories responding to the concerns of the industry over drug use and abuse in performance horses should continue to develop more sensitive methods of drug detection. The unwanted result of this increase in sensitivity is the detection of therapeutic medications days to weeks after administration. The adoption of decision or threshold concentrations for residues of nonpermitted medications should allow laboratories to focus their efforts on drugs of abuse in the performance horse industries and permit veterinarians to provide appropriate medical care to these equine athl...
Effects of topical administration of 0.005% latanoprost solution on eyes of clinically normal horses.
American journal of veterinary research    January 5, 2002   Volume 62, Issue 12 1945-1951 doi: 10.2460/ajvr.2001.62.1945
Willis AM, Diehl KA, Hoshaw-Woodard S, Kobayashi I, Vitucci MP, Schmall LM.To determine the effect of 0.005% latanoprost solution on intraocular pressure (IOP) of eyes of clinically normal horses and establish the frequency of adverse effects of drug administration. Methods: 20 adult clinically normal horses. Methods: IOP was recorded (7, 9, and 11 AM; 3, 5, and 7 PM) on days 1 and 2 (baseline), days 3 to 7 (treatment), and days 8 to 9 (follow-up). Latanoprost was administered to 1 randomly assigned eye of each horse every 24 hours during the treatment period, following the 7 AM IOP recording. Pupil size and the presence or absence of conjunctival hyperemia, epiphora...
Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals.
American journal of veterinary research    January 5, 2002   Volume 62, Issue 12 1870-1875 doi: 10.2460/ajvr.2001.62.1870
Jacks S, Giguère S, Gronwall PR, Brown MP, Merritt KA.To determine the pharmacokinetics of azithromycin and its concentration in body fluids and bronchoalveolar lavage cells in foals. Methods: 6 healthy 6- to 10-week-old foals. Methods: Azithromycin (10 mg/kg of body weight) was administered to each foal via i.v. and intragastric (i.g.) routes in a crossover design. After the first i.g. dose, 4 additional i.g. doses were administered at 24-hour intervals. A microbiologic assay was used to measure azithromycin concentrations in serum, peritoneal fluid, synovial fluid, pulmonary epithelial lining fluid (PELF), and bronchoalveolar (BAL) cells. Resul...
World association for the advancement of veterinary parasitology (WAAVP): second edition of guidelines for evaluating the efficacy of equine anthelmintics.
Veterinary parasitology    December 26, 2001   Volume 103, Issue 1-2 1-18 doi: 10.1016/s0304-4017(01)00574-x
Duncan JL, Abbott EM, Arundel JH, Eysker M, Klei TR, Krecek RC, Lyons ET, Reinemeyer C, Slocombe JO.These guidelines have been designed to assist in the planning, operation and interpretation of studies which would serve to assess the efficacy of drugs against internal parasites of horses. Although the term anthelmintic is used in the title and text, these guidelines include studies on drug efficacy against larvae of horse bot flies, Gasterophilus spp., which are non-helminth parasites commonly occurring in the stomach of horses. The advantages, disadvantages and application of critical and controlled tests are presented. Information is also provided on selection of animals, housing, feed, d...
Effect of romifidine on gastrointestinal motility, assessed by transrectal ultrasonography.
Equine veterinary journal    November 27, 2001   Volume 33, Issue 6 570-576 doi: 10.2746/042516401776563436
Freeman SL, England GC.A technique of transrectal ultrasonography was developed to investigate the effects of romifidine 80 and 120 microg/kg bwt on intestinal motility in the horse. Motility of the small intestine, caecum and left ventral colon were assessed following injection of romifidine and a saline control, using a blinded, cross-over study design in 6 horses. Measurements were taken at 15, 30, 60, 120, 180 and 240 min after drug administration. There was a slight nonsignificant decrease in motility in the control group over the 4 h study period. Both doses of romifidine produced a marked decrease in gastroin...
Drug treatment approved for equine neurological disease.
FDA consumer    November 8, 2001   Volume 35, Issue 5 6 
No abstract available
Measurement of ketoprofen in horse urine using gas chromatography-mass spectrometry.
Journal of veterinary pharmacology and therapeutics    November 7, 2001   Volume 24, Issue 5 315-319 doi: 10.1046/j.1365-2885.2001.00353.x
Kim JY, Kim SJ, Paeng KJ, Chung BC.A gas chromatographic-mass spectrometric (GC-MS) method for the determination of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), in horse urine by selected ion monitoring (SIM) mode is described. Urine samples (2 mL) were extracted by liquid-liquid extraction with diethyl ether. The residues were then evaporated, derivatized and injected into the GC-MS system. Validation of the GC-MS method in the SIM mode using flurbiprofen as the internal standard (IS) included linearity studies (10-10 000 ng/mL), recovery (95%) and limit of quantitation (LOQ) (10 ng/mL). The response was linear,...
Effects of intra-articular injections of bufexamac suspension in healthy horses.
American journal of veterinary research    October 11, 2001   Volume 62, Issue 10 1629-1635 doi: 10.2460/ajvr.2001.62.1629
Suominen MM, Tulamo RM, Anttila MO, Sankari SM, Király K, Lapveteläinen T, Helminen HJ.To evaluate the effects of intra-articular (IA) injections of bufexamac in horses, focusing particularly on the effects of bufexamac on articular cartilage. Methods: 20 Standardbreds. Methods: Horses were randomly allocated into 4 groups consisting of 5 horses each, and 20, 60, or 100 mg of bufexamac or 1 ml of sterile saline (0.9% NaCl) solution (control) was injected into 1 intercarpal joint at weekly intervals for 6 treatments (days 0, 7, 14, 21, 28, and 35). Clinical signs and results of hematologic, serum biochemical, and synovial fluid (SF) analyses and radiography were used to evaluate ...
Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses.
American journal of veterinary research    October 11, 2001   Volume 62, Issue 10 1606-1611 doi: 10.2460/ajvr.2001.62.1606
Latimer FG, Colitz CM, Campbell NB, Papich MG.To determine the pharmacokinetics of fluconazole in horses. Methods: 6 clinically normal adult horses. Methods: Fluconazole (10 mg/kg of body weight) was administered intravenously or orally with 2 weeks between treatments. Plasma fluconazole concentrations were determined prior to and 10, 20, 30, 40, and 60 minutes and 2, 4, 6, 8, 10, 12, 24, 36, 48, 60, and 72 hours after administration. A long-term oral dosing regimen was designed in which all horses received a loading dose of fluconazole (14 mg/kg) followed by 5 mg/kg every 24 hours for 10 days. Fluconazole concentrations were determined i...
Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses.
Equine veterinary journal    September 18, 2001   Volume 33, Issue 5 494-498 doi: 10.2746/042516401776254835
Gokbulut C, Nolan AM, McKellar QA.The present study was carried out to investigate whether the pharmacokinetics of avermectins or a milbemycin could explain their known or predicted efficacy in the horse. The avermectins, ivermectin (IVM) and doramectin (DRM), and the milbemycin, moxidectin (MXD), were each administered orally to horses at 200 microg/kg bwt. Blood and faecal samples were collected at predetermined times over 80 days (197 days for MXD) and 30 days, respectively, and plasma pharmacokinetics and faecal excretion determined. Maximum plasma concentrations (Cmax) (IVM: 21.4 ng/ml; DRM: 21.3 ng/ml; MXD: 30.1 ng/ml) w...
Interaction of cimetidine with equine hemoglobin.
Journal of veterinary pharmacology and therapeutics    September 14, 2001   Volume 24, Issue 4 299-302 doi: 10.1046/j.1365-2885.2001.00350.x
Hunter RP, Short CR, Dees AA.No abstract available
Elimination of doxepin isomers from the horse following intravenous application.
Journal of veterinary pharmacology and therapeutics    September 14, 2001   Volume 24, Issue 4 283-289 doi: 10.1046/j.1365-2885.2001.00345.x
Hagedorn HW, Meiser H, Zankl H, Schulz R.The tricyclic antidepressant doxepin, representing a 5:1 mixture of trans- and cis-isomers, owns tranquilizing properties. This compound has been associated with illicit medication of racing horses, and therefore should be considered in doping control. Because analysis of doxepin in equine body fluids has not been documented in the literature, a highly sensitive analytical method was developed to individually monitor the doxepin isomers in blood and urine of horses by the use of gas chromatography/mass spectrometry. Following a dose of 1 mg doxepin-HCl/kg intravenously (i.v.), both the isomers...
Analgesic effect of butorphanol and levomethadone in detomidine sedated horses.
Journal of veterinary medicine. A, Physiology, pathology, clinical medicine    September 14, 2001   Volume 48, Issue 6 337-342 doi: 10.1046/j.1439-0442.2001.00366.x
Schatzman U, Armbruster S, Stucki F, Busato A, Kohler I.The analgesic potency of butorphanol 25 microg/kg bodyweight (BW) and levomethadone 100 microg/kg BW, administered together with detomidine 10 microg/kg BW, was measured in twelve Warmblood horses in a randomized, blinded cross-over study. Detomidine with saline 10 ml 0.9% was used as placebo. The nociceptive threshold was determined using a constant current and a pneumatic pressure model for somatic pair Detomidine alone and in combination with butorphanol or levomethadone caused a significant temporary increase (P < 0.05) of the nociceptive threshold with a maximum effect within 15 min and a...
Corticosteroids alter the differentiated phenotype of articular chondrocytes.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society    August 24, 2001   Volume 19, Issue 4 688-695 doi: 10.1016/S0736-0266(00)00060-7
Fubini SL, Todhunter RJ, Burton-Wurster N, Vernier-Singer M, MacLeod JN.Experimental evidence suggests that recommended dosages of some corticosteroids used clinically as antiinflammatory agents for treating arthropathies damage articular cartilage, but low dosages may be chondroprotective. The purpose of this study was to evaluate how different concentrations of methylprednisolone affect chondrocyte function and viability. Articular cartilage and chondrocytes were obtained from young adult horses, 1.5-3.5 years of age. Corticosteroid-induced changes in collagen expression were studied at the transcriptional level by Northern blot analyses and at the translational...
Analyses of quaternary ammonium drugs in horse urine by capillary electrophoresis-mass spectrometry.
Electrophoresis    August 16, 2001   Volume 22, Issue 11 2201-2209 doi: 10.1002/1522-2683(20017)22:11<2201::AID-ELPS2201>3.0.CO;2-S
Tang FP, Leung GN, Wan TS.A capillary electrophoresis-mass spectrometry (CE-MS) method for the analysis of quaternary ammonium drugs in equine urine was developed. Quaternary ammonium drugs were first extracted from equine urine by ion-pair extraction and then analysed by CE-MS in the positive electrospray ionization (ESI) mode. Within 12 min, eight quaternary ammonium drugs, each at 1 ng/mL in horse urine, could be detected. The confirmation of these drugs in urine samples was achieved by capillary electrophoresis tandem mass spectrometry (CE-MS/MS). A direct comparison of this method was made with existing liquid chr...
Systematic analysis of acid, neutral and basic drugs in horse plasma by combination of solid-phase extraction, non-aqueous partitioning and gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications    August 7, 2001   Volume 758, Issue 2 235-248 doi: 10.1016/s0378-4347(01)00189-x
Takeda A, Tanaka H, Shinohara T, Ohtake I.A sample preparation method for mass chromatographic detection of doping drugs from horse plasma is described. Bond Elut Certify (1 g/6 ml) is used for the extraction of 4 ml of horse plasma. Fractionation is performed with 6 ml of CHCl3-Me2CO (8:2) and 5 ml of 1% TEA-MeOH according to its property. Simple and effective clean-up based on non-aqueous partitioning is adopted to remove co-eluted contaminants in both acid and basic fractions. Two kinds of 1-(N,N-diisopropylamino)-n-alkanes are co-injected with the sample into the GC-MS system for the calculation of the retention index. Total recov...
Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Haines GR, Brown MP, Gronwall RR, Merritt KA, Baltzley LK.Pharmacokinetics and distribution of orbifloxacin into body fluids and endometrium was studied in 6 mares after intragastric (IG) administration at a single dose rate of 7.5 mg/kg body weight. Orbifloxacin concentrations were serially measured in serum, synovial fluid, peritoneal fluid, urine, cerebrospinal fluid, and endometrial tissues over 24 hours. Minimum inhibitory concentrations of orbifloxacin were determined for 120 equine pathogens over an 11-month period. The mean peak serum concentration (Cmax) was 2.41+/-0.30 microg/mL at 1.5 hours after administration and decreased to 0.17+/-0.01...
Analgesic, hemodynamic, and respiratory effects induced by caudal epidural administration of meperidine hydrochloride in mares.
American journal of veterinary research    July 17, 2001   Volume 62, Issue 7 1001-1007 doi: 10.2460/ajvr.2001.62.1001
Skarda RT, Muir WW.To determine the analgesic, hemodynamic, and respiratory effects induced by caudal epidural administration of meperidine hydrochloride in mares. Methods: 7 healthy mares. Methods: Each mare received meperidine (5%; 0.8 mg/kg of body weight) or saline (0.9% NaCl) solution via caudal epidural injection on 2 occasions. At least 2 weeks elapsed between treatments. Degree of analgesia in response to noxious electrical, thermal, and skin and muscle prick stimuli was determined before and for 5 hours after treatment. In addition, cardiovascular and respiratory variables were measured and degree of se...
Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 2 89-98 doi: 10.1046/j.1365-2885.2001.00314.x
Harkins JD, Karpiesiuk W, Lehner A, Woods WE, Dirikolu L, Carter WG, Boyles J, Tobin T.This report evaluates the pharmacological responses, urinary detection and mass spectral confirmation of ropivacaine in horses. Ropivacaine, a potent local anesthetic (LA) recently introduced in human medicine, has an estimated highest no-effect dose (HNED) of about 0.4 mg/site as determined in our abaxial sesamoid block model. Apparent ropivacaine equivalents were detectable by ELISA screening using a mepivacaine ELISA test after administration of clinically effective doses. Mass spectral examination of postadministration urine samples showed no detectable parent ropivacaine, but a compound i...
Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 3 187-192 doi: 10.1046/j.1365-2885.2001.00326.x
Gardner SY, Papich MG.The pharmacokinetics of cefepime, a new fourth generation cephalosporin with enhanced antibacterial activity, was examined in neonatal foals and adult dogs. Cefepime was administered intravenously (i.v.) at a dose of 14 mg/kg to five neonatal foals and six adult dogs. Blood samples were collected in both groups of animals and plasma cefepime concentrations measured by reverse-phase high-performance liquid chromatography (HPLC). Cefepime concentrations in both groups of animals were described by a two-compartment pharmacokinetic model with elimination half-lives of 1.65 and 1.09 h for the foal ...
Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 3 179-185 doi: 10.1046/j.1365-2885.2001.00336.x
Verde CR, Simpson MI, Frigoli A, Landoni MF.Pharmacokinetic parameters were established for enantiomers of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen (KTP) administered as the racemic mixture at a dose of 2.2 mg/kg and as separate enantiomers, each at a dose of 1.1 mg/kg to a group of six horses (five mares and one gelding). A four-period cross-over study in a LPS-induced model of acute synovitis was used. After administration of the racemic mixture S(+)KTP was the predominant enantiomer in plasma as well as in synovial fluid. Unidirectional inversion of R(-) to S(+)KTP was demonstrated but the inversion was less marked ...
Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction.
Journal of the American Veterinary Medical Association    June 22, 2001   Volume 218, Issue 12 1961-1965 doi: 10.2460/javma.2001.218.1961
Henrikson SL, Rush BR.To determine the onset, magnitude, and duration of bronchodilation after administration of aerosolized salmeterol xinafoate in horses with recurrent airway obstruction. Methods: Randomized controlled study Methods: 6 horses with recurrent airway obstruction. Procedure Horses received aerosolized salmeterol (210 microg) or no treatment, using a crossover design. Salmeterol was administered, using a mask designed for aerosol delivery in horses. Subjective rating of airway obstruction (RAO), maximal change in pleural pressure (deltaPplmax), and pulmonary resistance (RL) were determined at baselin...
1 54 55 56 57 58 95